Complementary therapies in rheumatology: towards comprehensive management of rheumatic diseases
Main Article Content
Article Sidebar
Published
2025 December 30
Jorge Hernández
Luis Dulcey
Juan Therán
https://orcid.org/0009-0001-5758-5965
Luis Dulcey
Juan Therán
Abstract
La artritis reumatoide (AR) y el lupus eritematoso sistémico (LES) son enfermedades reumáticas que requieren un manejo adecuado. Esto ha sido posible en las últimas décadas a través de tratamientos con agentes biológicos y los inmunomoduladores. Sin embargo, estas enfermedades son crónicas, por lo que persisten síntomas como dolor, fatiga y rigidez articular. Sumados a los efectos secundarios de la farmacoterapia, han suscitado un mayor interés por utilizar terapias complementarias como parte de un enfoque integral.
How to Cite
1.
Hernández J, Dulcey L, Therán J. Complementary therapies in rheumatology: towards comprehensive management of rheumatic diseases. Rev. parag. reumatol. [Internet]. 2025 Dec. 30 [cited 2026 Oct. 19];11(2):91-2. Available from: https://revista.spr.org.py/index.php/spr/article/view/225
Downloads
Download data is not yet available.
Article Details
References
(1) López-Medina C, Moltó A, Gérald F, Dubremetz M, Grange L, Thibaud G, et al. Assessment of the adherence to disease-modifying drugs in patients with chronic inflammatory rheumatic diseases: Results of a survey of 1594 patients. Joint Bone Spine [Internet]. 2019 Oct 1 [cited 2024 Dec 8];86(5):610–4. Available from: https://pubmed.ncbi.nlm.nih.gov/30738192/
(2) De Cuyper E, De Gucht V, Maes S, Van Camp Y, De Clerck LS. Determinants of methotrexate adherence in rheumatoid arthritis patients. Clin Rheumatol [Internet]. 2016 May 1 [cited 2024 Dec 8];35(5):1335–9. Available from: https://pubmed.ncbi.nlm.nih.gov/26781783/
(3) Dhir V, Prasad CB, Kumar S, Kaul KK, Dung N, Naidu GSRSNK, et al. Long-term persistence of oral methotrexate and associated factors in rheumatoid arthritis: a retrospective cohort study. Rheumatol Int [Internet]. 2023 May 1 [cited 2024 Dec 8];43(5):867–73. Available from: https://pubmed.ncbi.nlm.nih.gov/36933068/
(4) Brzezińska O, Kuc A, Kobiałka D, Małecki D, Makowska J. Adherence with methotrexate in polish patients-Survey research results. Int J Clin Pract [Internet]. 2021 Mar 1 [cited 2024 Dec 8];75(3). Available from: https://pubmed.ncbi.nlm.nih.gov/32798326/
(5) Hope HF, Hyrich KL, Anderson J, Bluett J, Sergeant JC, Barton A, et al. The predictors of and reasons for non-adherence in an observational cohort of patients with rheumatoid arthritis commencing methotrexate. Rheumatology (Oxford) [Internet]. 2020 Jan 1 [cited 2024 Dec 8];59(1):213–23. Available from: https://pubmed.ncbi.nlm.nih.gov/31302692/
(2) De Cuyper E, De Gucht V, Maes S, Van Camp Y, De Clerck LS. Determinants of methotrexate adherence in rheumatoid arthritis patients. Clin Rheumatol [Internet]. 2016 May 1 [cited 2024 Dec 8];35(5):1335–9. Available from: https://pubmed.ncbi.nlm.nih.gov/26781783/
(3) Dhir V, Prasad CB, Kumar S, Kaul KK, Dung N, Naidu GSRSNK, et al. Long-term persistence of oral methotrexate and associated factors in rheumatoid arthritis: a retrospective cohort study. Rheumatol Int [Internet]. 2023 May 1 [cited 2024 Dec 8];43(5):867–73. Available from: https://pubmed.ncbi.nlm.nih.gov/36933068/
(4) Brzezińska O, Kuc A, Kobiałka D, Małecki D, Makowska J. Adherence with methotrexate in polish patients-Survey research results. Int J Clin Pract [Internet]. 2021 Mar 1 [cited 2024 Dec 8];75(3). Available from: https://pubmed.ncbi.nlm.nih.gov/32798326/
(5) Hope HF, Hyrich KL, Anderson J, Bluett J, Sergeant JC, Barton A, et al. The predictors of and reasons for non-adherence in an observational cohort of patients with rheumatoid arthritis commencing methotrexate. Rheumatology (Oxford) [Internet]. 2020 Jan 1 [cited 2024 Dec 8];59(1):213–23. Available from: https://pubmed.ncbi.nlm.nih.gov/31302692/
Section
LETTERS TO THE EDITOR
How to Cite
1.
Hernández J, Dulcey L, Therán J. Complementary therapies in rheumatology: towards comprehensive management of rheumatic diseases. Rev. parag. reumatol. [Internet]. 2025 Dec. 30 [cited 2026 Oct. 19];11(2):91-2. Available from: https://revista.spr.org.py/index.php/spr/article/view/225
Share
